Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Eledon Pharmaceuticals (NASDAQ:ELDN) Drops 8%: Biotech Pullback Puts Investors on Watch

• Eledon Pharmaceuticals (ELDN) fell about 8%, ranking among the biggest stock losers in the USA on a market-data screener.

Vinay Lochav | 26 June 2026

ENDRA Life Sciences (NASDAQ:NDRA) Plunges 31% as Traders Question the Next Catalyst

• ENDRA Life Sciences (NDRA) dropped roughly 31%, ranking among the biggest stock losers in the USA.

Vinay Lochav | 26 June 2026

Greenwich LifeSciences (NASDAQ:GLSI) Tumbles 15% as Biotech Investors Turn Cautious

• Greenwich LifeSciences (GLSI) fell about 15%, ranking among the biggest stock losers in the USA on a market-data screener.

Vinay Lochav | 26 June 2026

IceCure Medical (NASDAQ:ICCM) Falls 25%: Is the Market Losing Patience with This MedTech Story?

• The flag is based on the size of the share-price decline, not a verified catalyst.

Vinay Lochav | 26 June 2026

Aquestive Therapeutics (NASDAQ:AQST) Drops 11% as Biotech Momentum Reverses

• Aquestive Therapeutics (AQST) fell about 11%, ranking among the biggest stock losers in the USA on a market-data screener.

Vinay Lochav | 26 June 2026

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Falls 12%: What Investors Should Watch After the Drop

• Armata Pharmaceuticals (ARMP) fell about 12%, ranking among the biggest stock losers in the USA on a market-data screener.

Vinay Lochav | 26 June 2026

ARS Pharmaceuticals (NASDAQ:SPRY) Slides 24%: What Triggered the Sharp Biotech Pullback?

• The flag reflects the size of the share-price decline, not a verified catalyst.

Vinay Lochav | 26 June 2026

Zenas BioPharma (NASDAQ:ZBIO) Pops 13% as Biotech Investors Hunt the Next Breakout

• Zenas BioPharma (ZBIO) was identified as one of the top gaining US stocks, rising around 13% in a single trading session.

Vinay Lochav | 26 June 2026

Revvity (NYSE:RVTY) Rallies as Life-Science Tools Stocks Regain Market Confidence

• Revvity (RVTY) was identified as one of the top gaining US stocks, rising notably in a single trading session.

Vinay Lochav | 26 June 2026

SELLAS Life Sciences (NASDAQ:SLS) Rallies 15% as Biotech Speculation Heats Up

• SELLAS Life Sciences (SLS) was identified as one of the top gaining US stocks, rising roughly 15% in a single trading session.

Vinay Lochav | 26 June 2026
Support

Hi! How can we help you today?

Loading…